Wigard Kloosterman

Wigard Kloosterman

Company: CureVac Netherlands

Job title: Senior Director Cancer Antigen Discovery & Validation


Categorizing Most Effective Neoantigens to Ensure Greatest Clinical Benefits 8:30 am

Filtering the different neoantigen sub-categories Sequencing the whole genome to identify neoantigens arising from genomic rearrangements Identifying the different categories of antigens and rationalizing the most preferred subsetRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.